David F. Jenkins - Concepedia

Author

David F. Jenkins

Also Known As

D. F. Jenkins, D. Jenkins, D.F. Jenkins, DAVID JENKINS, David F Jenkins, David F. Jenkins, David Jenkins, Jenkins, David, Jenkins, David F.

132

Publications

754

Citations

H-Index

Concepts

All Affiliations

Boston University University of Utah City of Hope AstraZeneca (United Kingdom)AstraZeneca (United States)

About

David F. Jenkins is an author at Boston University specializing in medicine, engineering, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	5	5	86
2	Medicine	5	5	154
3	Language Studies	1	1	10
4	Social Sciences	1	1	27
5	Biology	1	1	82

David F. Jenkins

Publications

619

Citations

H-Index

Page 1

	Year	Citations
Combating subclonal evolution of resistant cancer phenotypes Samuel W. Brady, Jasmine A. McQuerry, Stephen Piccolo, Nature Communications	2017	164
Alternative empirical Bayes models for adjusting for batch effects in genomic studies Yuqing Zhang, David F. Jenkins, Solaiappan Manimaran, BMC Bioinformatics	2018	117
Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge Eating Stacey L. Kirkpatrick, Lisa R. Goldberg, Neema Yazdani, Biological Psychiatry ObesityAppetiteBiologyEnergy HomeostasisEating Disorders	2016	82
An introduction to nonlinear analysis of fuzzy control systems David F. Jenkins, Kevin M. Passino Journal of Intelligent & Fuzzy Systems Stability AnalysisNonlinear ControlFuzzy LogicFuzzy SystemsSteady State	1999	33
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations Azadeh C. Bashi, Elizabeth A. Coker, Krishna C. Bulusu, Cancer Discovery	2024	30
Casein kinase 1‐epsilon deletion increases mu opioid receptor‐dependent behaviors and binge eating1 Lisa R. Goldberg, Stacey L. Kirkpatrick, Narges Yazdani, Genes Brain & Behavior PsychopharmacologyCsnk1e DeletionExperimental PharmacologySocial SciencesMolecular Pharmacology	2017	27
Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes Jasmine A. McQuerry, David F. Jenkins, Susan E. Yost, BMC Cancer	2019	27
Comparing tuberculosis gene signatures in malnourished individuals using the TBSignatureProfiler W. Evan Johnson, Aubrey R. Odom-Mabey, Chelsie Cintron, BMC Infectious Diseases	2021	23
Prioritisation of structural variant calls in cancer genomes Miika Ahdesmäki, Brad Chapman, Pablo Cingolani, PeerJ Functional GenomicsEngineeringSomatic VariantTumor HeterogeneityShort Read Dna-sequencing	2017	21
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment Mark Roschewski, Manish R. Patel, Patrick M. Reagan, Clinical Cancer Research	2023	21

Page 1